Found: 94
Select item for more details and to access through your institution.
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 2, p. 371, doi. 10.1007/s10637-014-0194-2
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 331, doi. 10.1007/s10637-008-9129-0
- By:
- Publication type:
- Article
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 3, p. 233, doi. 10.1007/s10637-008-9115-6
- By:
- Publication type:
- Article
Sequencing antigen‐targeting antibodies and cellular therapies in adults with relapsed/refractory B‐cell acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 666, doi. 10.1002/ajh.26853
- By:
- Publication type:
- Article
A multi‐institutional comparison of mitoxantrone, etoposide, and cytarabine vs high‐dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 8, p. 937, doi. 10.1002/ajh.25838
- By:
- Publication type:
- Article
Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 583, doi. 10.1002/ajh.25783
- By:
- Publication type:
- Article
Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicin.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 4, p. 408, doi. 10.1002/ajh.25394
- By:
- Publication type:
- Article
Treatment of young adults with Philadelphia‐negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper‐CVAD vs. pediatric‐inspired regimens.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1254, doi. 10.1002/ajh.25229
- By:
- Publication type:
- Article
Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemia.
- Published in:
- American Journal of Hematology, 2005, v. 79, n. 2, p. 119, doi. 10.1002/ajh.20354
- By:
- Publication type:
- Article
The Impact of Maternity Leave Laws on Cesarean Delivery.
- Published in:
- B.E. Journal of Economic Analysis & Policy, 2016, v. 16, n. 1, p. 321, doi. 10.1515/bejeap-2015-0015
- By:
- Publication type:
- Article
Burkitt Lymphoma/Leukemia: Improving Prognosis.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S231, doi. 10.3816/CLM.2009.s.017
- By:
- Publication type:
- Article
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-018-0125-6
- By:
- Publication type:
- Article
Progressive Transformation of Germinal Centers.
- Published in:
- Acta Haematologica, 2002, v. 108, n. 1, p. 33, doi. 10.1159/000063057
- By:
- Publication type:
- Article
CD5+ Immunophenotype in the Bone Marrow but Not in the Peripheral Blood in a Patient with Hairy Cell Leukemia.
- Published in:
- Acta Haematologica, 2000, v. 103, n. 4, p. 210, doi. 10.1159/000041052
- By:
- Publication type:
- Article
CGG-repeat polymorphism of the BCR gene rules out predisposing alleles leading to the philadelphia chromosome.
- Published in:
- Genes, Chromosomes & Cancer, 1994, v. 9, n. 2, p. 141, doi. 10.1002/gcc.2870090211
- By:
- Publication type:
- Article
Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
- Published in:
- American Journal of Hematology, 1996, v. 52, n. 1, p. 42, doi. 10.1002/(SICI)1096-8652(199605)52:1<42::AID-AJH7>3.0.CO;2-6
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 725, doi. 10.1016/j.clml.2021.07.009
- By:
- Publication type:
- Article
OTS167 Inhibits FLT3 Expression in FLT3 Mutant Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S239, doi. 10.1016/j.clml.2019.07.133
- By:
- Publication type:
- Article
Efficacy and Safety of Inotuzumab Ozogamicin in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Treated in the INO-VATE Trial: Outcomes by Salvage-Treatment Phase.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S191, doi. 10.1016/j.clml.2019.07.035
- By:
- Publication type:
- Article
More or Less? Impact of Dose Number on Outcomes of Patients with Acute Lymphoblastic Leukemia Treated with Inotuzumab Ozogamicin.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S190, doi. 10.1016/j.clml.2019.07.034
- By:
- Publication type:
- Article
Combination BCL-2 Inhibitor Therapy with Venetoclax and Navitoclax in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S184, doi. 10.1016/j.clml.2019.07.022
- By:
- Publication type:
- Article
Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing Clinician.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Phase 3 Study of CPX-351 versus Conventional 7+3 Cytarabine and Daunorubicin: Subanalysis of Patients with Secondary Acute Myeloid Leukemia (sAML) with Refractory Anemia with Excess of Blasts in Transformation (RAEB-t).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S208, doi. 10.1016/j.clml.2018.07.063
- By:
- Publication type:
- Article
Management of Important Adverse Events Associated with Inotuzumab Ozogamicin in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S261, doi. 10.1016/j.clml.2017.07.027
- By:
- Publication type:
- Article
Axi-cel, an Anti-CD19 Chimeric Antigen Receptor (CAR) T cell Therapy in Adult Patients (Pts) With Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL) in the ZUMA-3 Trial: Preliminary Results of Novel Safety Interventions.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S253, doi. 10.1016/j.clml.2017.07.014
- By:
- Publication type:
- Article
A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The Academic Labor Market for Economists: 1995-96.
- Published in:
- Atlantic Economic Journal, 2000, v. 28, n. 2, p. 164, doi. 10.1007/BF02298359
- By:
- Publication type:
- Article
The longer-term labor market impacts of paid parental leave.
- Published in:
- Growth & Change, 2021, v. 52, n. 2, p. 838, doi. 10.1111/grow.12486
- By:
- Publication type:
- Article
Predicting displaced worker industry switching: Targeting...
- Published in:
- Growth & Change, 1998, v. 29, n. 1, p. 3, doi. 10.1111/1468-2257.00073
- By:
- Publication type:
- Article
OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00433-3
- By:
- Publication type:
- Article
Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00345-8
- By:
- Publication type:
- Article
Intergroup Trial C10403: A Pediatric Treatment Approach to Improve Outcomes in Adolescents and Young Adults with Acute Lymphoblastic Leukemia.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2011, v. 1, n. 2, p. 107
- By:
- Publication type:
- Article
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01553-6
- By:
- Publication type:
- Article
Efficacy and tolerability of a modified pediatric‐inspired intensive regimen for acute lymphoblastic leukemia in older adults.
- Published in:
- EJHaem, 2021, v. 2, n. 3, p. 413, doi. 10.1002/jha2.224
- By:
- Publication type:
- Article
The Labor Market for New Ph.D. Economists.
- Published in:
- Journal of Economic Perspectives, 1999, v. 13, n. 3, p. 115, doi. 10.1257/jep.13.3.115
- By:
- Publication type:
- Article
Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1187268
- By:
- Publication type:
- Article
Agricultural Graduate Earnings: The Impacts of College, Career, and Gender.
- Published in:
- American Journal of Agricultural Economics, 1999, v. 81, n. 4, p. 785, doi. 10.2307/1244324
- By:
- Publication type:
- Article
New Approaches to Treating Challenging Subtypes of ALL in AYA Patients.
- Published in:
- Current Hematologic Malignancy Reports, 2020, v. 15, n. 6, p. 424, doi. 10.1007/s11899-020-00597-y
- By:
- Publication type:
- Article
Minimal Residual Disease in Acute Myeloid Leukemia-Current Status and Future Perspectives.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 2, p. 132, doi. 10.1007/s11899-015-0260-7
- By:
- Publication type:
- Article
Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 750, doi. 10.1002/cncr.35078
- By:
- Publication type:
- Article
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2308, doi. 10.1002/cncr.34780
- By:
- Publication type:
- Article
Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome–positive relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 905, doi. 10.1002/cncr.33321
- By:
- Publication type:
- Article
Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1238, doi. 10.1111/bjh.19250
- By:
- Publication type:
- Article
Impact of number of cycles on outcomes of patients with relapsed or refractory acute lymphoblastic leukaemia treated with inotuzumab ozogamicin.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 3, p. e77, doi. 10.1111/bjh.17029
- By:
- Publication type:
- Article
Clinical outcomes of IDH2‐mutated advanced‐phase Ph‐negative myeloproliferative neoplasms treated with enasidenib.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 1, p. e48, doi. 10.1111/bjh.16709
- By:
- Publication type:
- Article
REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 6, p. 796, doi. 10.1111/bjh.13214
- By:
- Publication type:
- Article
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 4, p. 497, doi. 10.1111/bjh.12775
- By:
- Publication type:
- Article
Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase chronic myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 2, p. 223, doi. 10.1111/bjh.12618
- By:
- Publication type:
- Article